Bloomberg BusinessweekBloomberg Businessweek

All Eyes on Gilead

View descriptionShare

Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.

Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Businessweek

    4,384 clip(s)

Bloomberg Businessweek

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance  
Social links
Follow podcast
Recent clips
Browse 4,387 clip(s)